drugset / Trial / NCT02689999
The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity
NaSingle-groupOpen-labelTreatment
Summary
It is planned to investigate the effect of dexrabeprazole on gastric acid primarily, and then gastroesophageal reflux disease (GERD) symptoms, intraesophageal acidity (reflux) and impedance kinetics.
Timeline
- Start
- 2016-02
- Primary completion
- 2017-05
- Completion
- 2017-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexrabeprazole | Small molecule | 10 mg | — |